Gadopentetic acid

Magnevist

469 MG / ML SolutionCanadaMarketedAuthorised 31 Dec 1992

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Gadopentetic acid

Magnevist

469 MG / ML SolutionCanadaMarketedAuthorised 31 Dec 1992

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Gadopentetic acid
Strength: 469 MG / ML
Dosage form: Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 31 Dec 1992
Registration: DIN 01989987
Marketing authorisation holder: Bayer INC
ATC code: V08CA01
Group: Various
Supply: ETHICAL

Canada

Cancelled